205 related articles for article (PubMed ID: 12727871)
21. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
23. High-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes.
Groth A; Willumsen BM
Cell Signal; 2005 Sep; 17(9):1063-73. PubMed ID: 15993748
[TBL] [Abstract][Full Text] [Related]
24. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity.
Barette C; Jariel-Encontre I; Piechaczyk M; Piette J
Oncogene; 2001 Feb; 20(5):551-62. PubMed ID: 11313987
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
Law M; Forrester E; Chytil A; Corsino P; Green G; Davis B; Rowe T; Law B
Cancer Res; 2006 Jan; 66(2):1070-80. PubMed ID: 16424043
[TBL] [Abstract][Full Text] [Related]
26. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
27. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
Akashi M; Osawa Y; Koeffler HP; Hachiya M
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
Sheng G; Bernabe KQ; Guo J; Warner BW
Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
[TBL] [Abstract][Full Text] [Related]
31. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
Wu Y; Luo H; Kanaan N; Wu J
J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression.
Del Sal G; Murphy M; Ruaro E; Lazarevic D; Levine AJ; Schneider C
Oncogene; 1996 Jan; 12(1):177-85. PubMed ID: 8552389
[TBL] [Abstract][Full Text] [Related]
33. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
34. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
[TBL] [Abstract][Full Text] [Related]
35. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
36. Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling.
Bao W; Thullberg M; Zhang H; Onischenko A; Strömblad S
Mol Cell Biol; 2002 Jul; 22(13):4587-97. PubMed ID: 12052868
[TBL] [Abstract][Full Text] [Related]
37. Suppression of oncogenic transformation by hypothemycin associated with accelerated cyclin D1 degradation through ubiquitin-proteasome pathway.
Sonoda H; Omi K; Hojo K; Nishida K; Omura S; Sugita K
Life Sci; 1999; 65(4):381-94. PubMed ID: 10421424
[TBL] [Abstract][Full Text] [Related]
38. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells.
Pruitt K; Pestell RG; Der CJ
J Biol Chem; 2000 Dec; 275(52):40916-24. PubMed ID: 11007784
[TBL] [Abstract][Full Text] [Related]
39. Proteasome-dependent downregulation of p21(Waf1/Cip1) induced by reactive oxygen species.
Xie S; Wang Q; Luo L; Ruan Q; Liu T; Jhanwar-Uniyal M; Darzynkiewicz Z; Traganos F; Dai W
J Interferon Cytokine Res; 2002 Sep; 22(9):957-63. PubMed ID: 12396717
[TBL] [Abstract][Full Text] [Related]
40. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Diehl JA; Cheng M; Roussel MF; Sherr CJ
Genes Dev; 1998 Nov; 12(22):3499-511. PubMed ID: 9832503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
